ADVERSE EFFECTS OF BIOLOGICS IN RHEUMATOID ARTHRITIS: ARE THEY DIFFERENT FROM SPONDYLOARTHRITIS?

被引：0
|
作者：
Jradi, S. [1 ]
Mahmoud, I. [1 ]
Saidane, O. [1 ]
Sahli, H. [1 ]
Tekaya, R. [1 ]
Abdelmoula, L. [1 ]
机构：
[1] Tunisia Charles Nicolle Hosp, Rhumatol Dept, Tunis, Tunisia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2015年 / 74卷
关键词：
D O I：
10.1136/annrheumdis-2015-eular.6444
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
THU0258
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [1] Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis
    Zheni Stavre
    Katherine Upchurch
    Jonathan Kay
    Ellen M. Gravallese
    Current Rheumatology Reports, 2016, 18
  • [2] Differential Effects of Inflammation on Bone and Response to Biologics in Rheumatoid Arthritis and Spondyloarthritis
    Stavre, Zheni
    Upchurch, Katherine
    Kay, Jonathan
    Gravallese, Ellen M.
    CURRENT RHEUMATOLOGY REPORTS, 2016, 18 (12)
  • [3] Incidence of Infectious Adverse Events in Patients With Rheumatoid Arthritis and Spondyloarthritis on Biologic Drugs-Data From the Brazilian Registry for Biologics Monitoring
    Cecconi, Mariana
    Ranza, Roberto
    Titton, David C.
    Moraes, Julio C. B.
    Bertolo, Manoel
    Bianchi, Washington
    Brenol, Claiton
    Carvalho, Hellen M.
    de Castro, Glaucio R. W.
    Costa, Izaias P.
    Cunha, Maria F. L.
    Duarte, Angela
    Fernandes, Vander
    Freire, Marlene
    Louzada-Junior, Paulo
    Macieira, Jose C.
    Miranda, Jose R. S.
    Pereira, Ivanio A.
    Pinheiro, Geraldo R. C.
    Stadler, Barbara
    Toledo, Roberto A.
    Valim, Valeria
    Descalzo, Miguel A.
    Pinto, Rogerio M. C.
    Laurindo, Ieda
    JCR-JOURNAL OF CLINICAL RHEUMATOLOGY, 2020, 26 (02) : 73 - 78
  • [4] Positive Effects of Biologics on Osteoporosis in Rheumatoid Arthritis
    Kim, Yunkyung
    Kim, Geun-Tae
    JOURNAL OF RHEUMATIC DISEASES, 2023, 30 (01): : 3 - 17
  • [5] COMORBIDITY BURDEN IS HIGH IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS PATIENTS STARTING BIOLOGICS AND PREDICTS THE INCIDENCE OF SERIOUS ADVERSE EVENTS DURING THERAPY
    Flouri, I.
    Repa, A.
    Avgustidis, N.
    Kougkas, N.
    Eskitzis, A.
    Sali, A. Molla Ismail
    Pitsigavdaki, S.
    Pateromichelaki, K.
    Kalogiannaki, E.
    Terizaki, M.
    Bertsias, G.
    Sidiropoulos, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 523 - 523
  • [6] Incidence and Prevalence of Major Adverse Cardiovascular Events in Rheumatoid Arthritis, Psoriatic Arthritis, and Axial Spondyloarthritis
    Lauper, Kim
    Courvoisier, Delphine S.
    Chevallier, Paola
    Finckh, Axel
    Gabay, Cem
    ARTHRITIS CARE & RESEARCH, 2018, 70 (12) : 1756 - 1763
  • [7] ARE CO-MORBIDITIES DURING RHEUMATOID ARTHRITIS DIFFERENT FROM THOSE IN ANKYLOSING SPONDYLOARTHRITIS ?
    El Achek, M. A.
    Jguirim, M.
    Farhat, A.
    Braham, M.
    Bejia, I
    Touzi, M.
    Zrour, S.
    Bergaoui, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1358 - 1358
  • [8] Treatment of rheumatoid arthritis with biologics
    Panayi, GS
    SCHWEIZERISCHE MEDIZINISCHE WOCHENSCHRIFT, 1996, 126 : S22 - S23
  • [9] Adverse Events and Persistency of Biologics in Rheumatoid Arthritis Patients with Interstitial Lung Disease
    Kim, Dam
    Cho, Soo-Kyung
    Won, Soyoung
    Cha, Hoon-Suk
    Choi, Chan-Bum
    Hong, Seung-Jae
    Lee, Jisoo
    Sheen, Dong-Hyuk
    Yoo, Dae-Hyun
    Bae, Sang-Cheol
    Sung, Yoon-Kyoung
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [10] SEVERITY FACTORS IN RHEUMATOID ARTHRITIS AND SPONDYLOARTHRITIS IN NEWLY TREATED PATIENTS WITH BIOLOGICS: SURVEY OF THE BINAR REGISTRY
    Hachfi, H.
    Khalifa, D.
    Ben Chekaya, N.
    Brahem, M.
    Themri, H.
    Abdelmoula, L.
    Baklouti, S.
    Bergaoui, N.
    Bouajina, E.
    Elleuch, M.
    Gharsallah, I.
    Kchir, M. M.
    Kochbati, S.
    Laatar, A.
    Mohamed, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1445 - 1445
12345